Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosomes, PRP, and Steroids in Post-Herpetic Neuralgia
NCT07565844Recruiting
- Sponsor
- Zagazig University
- Start
- Feb 2025
- Primary completion
- Aug 2026
- Modality
- Adipose-derived MSCs, Lipid-based Nanoparticles, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised trial of endothelial progenitor cell-derived exosomes and platelet-rich plasma in postherpetic neuralgia (PHN) (3 arms), sponsored by Zagazig University. Primary endpoint: Visual Analog Scale at 6 weeks. Started Feb 2025; status: recruiting.
02
Drugs
endothelial progenitor cell-derived exosomesplatelet-rich plasma
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT07565844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07565844.